말초신경자극기 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 모달리티별, 용도별, 접속 방식별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

Peripheral Nerve Stimulators Market Summary

The global peripheral nerve stimulators market size was estimated at USD 271.79 million in 2024 and is projected to reach USD 680.30 million by 2033, growing at a CAGR of 10.89% from 2025 to 2033. The rising prevalence of chronic pain disorders, increasing preference for minimally invasive and non-opioid therapies, and continuous advancements in neuromodulation technologies are the primary driving factors contributing to the growth of the industry.

The rising prevalence of chronic pain disorders is one of the key driving factors of the peripheral nerve stimulators industry. Conditions like neuropathic pain, migraines, and post-surgical pain often cause long-term disability, while traditional treatments such as opioids carry risks of addiction and limited efficacy. For instance, according to recent data published by Brain Research UK, the following facts and statistics highlight the burden of neurological conditions in the UK:

Global Peripheral Nerve Stimulators Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global peripheral nerve stimulators market report based on product, modality, connectivity, application, end use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Systems
  • Implantable
  • Non-implantable
• Handheld
• Others
• Wearables/Accessories
• Modality Outlook (Revenue, USD Million, 2021 - 2033)
• Rechargeable
• Non-rechargeable
• Connectivity Outlook (Revenue, USD Million, 2021 - 2033)
• Wired
• Wireless
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Diabetic Peripheral Neuropathy Pain
• Chronic Musculoskeletal Pain
• Complex Regional Pain Syndrome (CRPS)
• Headache and migraine disorders
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals and Clinics
• Ambulatory Surgical Centers (ASCs)
• Physiotherapy/Rehabilitation Centers
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product Type
  • 1.1.2. Modality
  • 1.1.3. Application
  • 1.1.4. Connectivity
  • 1.1.5. End-use
  • 1.1.6. Regional scope
  • 1.1.7. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives
  • 1.9.1. Objective 1
  • 1.9.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Peripheral Nerve Stimulators Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising prevalence of chronic pain disorders
    • 3.2.1.2. Growing preference for minimally invasive therapies
    • 3.2.1.3. Opioid crisis and shift toward non-opioid pain management
    • 3.2.1.4. Expanding applications beyond chronic pain
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost of devices and procedures
    • 3.2.2.2. Risk of complications and device-related issues
  • 3.2.3. Market opportunity analysis
    • 3.2.3.1. Expansion into new indications
    • 3.2.3.2. Adoption in outpatient & home-care settings
    • 3.2.3.3. Rising demand for personalized pain management
  • 3.2.4. Market challenge analysis
    • 3.2.4.1. Competition from alternative therapies
    • 3.2.4.2. Patient selection challenges
• 3.3. Peripheral Nerve Stimulators Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. Peripheral Nerve Stimulators Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Peripheral Nerve Stimulators Market Product Movement Analysis
• 4.3. Global Peripheral Nerve Stimulators Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 4.4. Systems
  • 4.4.1. Systems market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.4.1.1. Implantable
      • 4.4.1.1.1. Implantable market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.4.1.2. Non-implantable
      • 4.4.1.2.1. Non-implantable market estimates and forecasts for 2021 to 2033 (USD Million)
        • 4.4.1.2.1.1. Handheld
          • 4.4.1.2.1.1.1. Handheld market estimates and forecasts for 2021 to 2033 (USD Million)
        • 4.4.1.2.1.2. Others
          • 4.4.1.2.1.1.1. Handheld market estimates and forecasts for 2021 to 2033 (USD Million)
• 4.5. Wearables/Accessories
  • 4.5.1. Wearables/Accessories market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 5. Peripheral Nerve Stimulators Market: Modality Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Peripheral Nerve Stimulators Market Modality Movement Analysis
• 5.3. Global Peripheral Nerve Stimulators Market Size & Trend Analysis, by Modality, 2021 to 2033 (USD Million)
• 5.4. Rechargeable
  • 5.4.1. Rechargeables market estimates and forecasts for 2021 to 2033 (USD Million)
• 5.5. Non-Rechargeable
  • 5.5.1. Non-rechargeable market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 6. Peripheral Nerve Stimulators Market: Application Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Peripheral Nerve Stimulators Market Application Movement Analysis
• 6.3. Global Peripheral Nerve Stimulators Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 6.4. Diabetic Peripheral Neuropathy Pain
  • 6.4.1. Diabetic peripheral neuropathy pain market estimates and forecasts for 2021 to 2033 (USD Million)
• 6.5. Chronic Musculoskeletal Pain
  • 6.5.1. Chronic musculoskeletal pain market estimates and forecasts for 2021 to 2033 (USD Million)
• 6.6. Complex Regional Pain Syndrome (CRPS)
  • 6.6.1. Complex regional pain syndrome (CRPS) market estimates and forecasts for 2021 to 2033 (USD Million)
• 6.7. Headache and Migraine Disorders
  • 6.7.1. Headache and migraine disorders market estimates and forecasts for 2021 to 2033 (USD Million)
• 6.8. Others
  • 6.8.1. Others market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 7. Peripheral Nerve Stimulators Market: Connectivity Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Peripheral Nerve Stimulators Market Connectivity Movement Analysis
• 7.3. Global Peripheral Nerve Stimulators Market Size & Trend Analysis, by Connectivity, 2021 to 2033 (USD Million)
• 7.4. Wired
  • 7.4.1. Wired market estimates and forecasts for 2021 to 2033 (USD Million)
• 7.5. Wireless
  • 7.5.1. Wireless market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 8. Peripheral Nerve Stimulators: End Use Estimates & Trend Analysis

• 8.1. Segment Dashboard
• 8.2. Global Peripheral Nerve Stimulators Market End Use Movement Analysis
• 8.3. Global Peripheral Nerve Stimulators Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 8.4. Hospitals and Clinics
  • 8.4.1. Hospitals and Clinics market estimates and forecasts for 2021 to 2033 (USD Million)
• 8.5. Ambulatory Surgical Centers (ASCs)
  • 8.5.1. Specialty clinics market estimates and forecasts for 2021 to 2033 (USD Million)
• 8.6. Physiotherapy/Rehabilitation Centers
  • 8.6.1. Ambulatory surgery centers market estimates and forecasts for 2021 to 2033 (USD Million)
• 8.7. Others
  • 8.7.1. Others market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 9. Peripheral Nerve Stimulators Market: Regional Estimates & Trend Analysis

• 9.1. Regional Dashboard
• 9.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
• 9.3. North America
  • 9.3.1. Market estimates and forecast, 2021 - 2033 (Revenue, USD Million)
  • 9.3.2. U.S.
    • 9.3.2.1. Key country dynamics
    • 9.3.2.2. Competitive scenario
    • 9.3.2.3. Regulatory framework
    • 9.3.2.4. Reimbursement scenario
    • 9.3.2.5. U.S. market estimates and forecasts, 2021 - 2033
  • 9.3.3. Canada
    • 9.3.3.1. Key country dynamics
    • 9.3.3.2. Competitive scenario
    • 9.3.3.3. Regulatory framework
    • 9.3.3.4. Reimbursement scenario
    • 9.3.3.5. Canada market estimates and forecasts, 2021 - 2033
  • 9.3.4. Mexico
    • 9.3.4.1. Key country dynamics
    • 9.3.4.2. Competitive scenario
    • 9.3.4.3. Regulatory framework
    • 9.3.4.4. Reimbursement scenario
    • 9.3.4.5. Mexico market estimates and forecasts, 2021 - 2033
• 9.4. Europe
  • 9.4.1. UK
    • 9.4.1.1. Key country dynamics
    • 9.4.1.2. Competitive scenario
    • 9.4.1.3. Regulatory framework
    • 9.4.1.4. Reimbursement scenario
    • 9.4.1.5. UK market estimates and forecasts, 2021 - 2033
  • 9.4.2. Germany
    • 9.4.2.1. Key country dynamics
    • 9.4.2.2. Competitive scenario
    • 9.4.2.3. Regulatory framework
    • 9.4.2.4. Reimbursement scenario
    • 9.4.2.5. Germany market estimates and forecasts, 2021 - 2033
  • 9.4.3. France
    • 9.4.3.1. Key country dynamics
    • 9.4.3.2. Competitive scenario
    • 9.4.3.3. Regulatory framework
    • 9.4.3.4. Reimbursement scenario
    • 9.4.3.5. France market estimates and forecasts, 2021 - 2033
  • 9.4.4. Italy
    • 9.4.4.1. Key country dynamics
    • 9.4.4.2. Competitive scenario
    • 9.4.4.3. Regulatory framework
    • 9.4.4.4. Reimbursement scenario
    • 9.4.4.5. Italy market estimates and forecasts, 2021 - 2033
  • 9.4.5. Spain
    • 9.4.5.1. Key country dynamics
    • 9.4.5.2. Competitive scenario
    • 9.4.5.3. Regulatory framework
    • 9.4.5.4. Reimbursement scenario
    • 9.4.5.5. Spain market estimates and forecasts, 2021 - 2033
  • 9.4.6. Denmark
    • 9.4.6.1. Key country dynamics
    • 9.4.6.2. Competitive scenario
    • 9.4.6.3. Regulatory framework
    • 9.4.6.4. Reimbursement scenario
    • 9.4.6.5. Denmark market estimates and forecasts, 2021 - 2033
  • 9.4.7. Sweden
    • 9.4.7.1. Key country dynamics
    • 9.4.7.2. Competitive scenario
    • 9.4.7.3. Regulatory framework
    • 9.4.7.4. Reimbursement scenario
    • 9.4.7.5. Sweden market estimates and forecasts, 2021 - 2033
  • 9.4.8. Norway
    • 9.4.8.1. Key country dynamics
    • 9.4.8.2. Competitive scenario
    • 9.4.8.3. Regulatory framework
    • 9.4.8.4. Reimbursement scenario
    • 9.4.8.5. Norway market estimates and forecasts, 2021 - 2033
• 9.5. Asia Pacific
  • 9.5.1. Japan
    • 9.5.1.1. Key country dynamics
    • 9.5.1.2. Competitive scenario
    • 9.5.1.3. Regulatory framework
    • 9.5.1.4. Reimbursement scenario
    • 9.5.1.5. Japan market estimates and forecasts, 2021 - 2033
  • 9.5.2. India
    • 9.5.2.1. Key country dynamics
    • 9.5.2.2. Competitive scenario
    • 9.5.2.3. Regulatory framework
    • 9.5.2.4. Reimbursement scenario
    • 9.5.2.5. India market estimates and forecasts, 2021 - 2033
  • 9.5.3. China
    • 9.5.3.1. Key country dynamics
    • 9.5.3.2. Competitive scenario
    • 9.5.3.3. Regulatory framework
    • 9.5.3.4. Reimbursement scenario
    • 9.5.3.5. China market estimates and forecasts, 2021 - 2033
  • 9.5.4. South Korea
    • 9.5.4.1. Key country dynamics
    • 9.5.4.2. Competitive scenario
    • 9.5.4.3. Regulatory framework
    • 9.5.4.4. Reimbursement scenario
    • 9.5.4.5. South Korea market estimates and forecasts, 2021 - 2033
  • 9.5.5. Australia
    • 9.5.5.1. Key country dynamics
    • 9.5.5.2. Competitive scenario
    • 9.5.5.3. Regulatory framework
    • 9.5.5.4. Reimbursement scenario
    • 9.5.5.5. Australia market estimates and forecasts, 2021 - 2033
  • 9.5.6. Thailand
    • 9.5.6.1. Key country dynamics
    • 9.5.6.2. Competitive scenario
    • 9.5.6.3. Regulatory framework
    • 9.5.6.4. Reimbursement scenario
    • 9.5.6.5. Thailand market estimates and forecasts, 2021 - 2033
• 9.6. Latin America
  • 9.6.1. Brazil
    • 9.6.1.1. Key country dynamics
    • 9.6.1.2. Competitive scenario
    • 9.6.1.3. Regulatory framework
    • 9.6.1.4. Reimbursement scenario
    • 9.6.1.5. Brazil market estimates and forecasts, 2021 - 2033
  • 9.6.2. Argentina
    • 9.6.2.1. Key country dynamics
    • 9.6.2.2. Competitive scenario
    • 9.6.2.3. Regulatory framework
    • 9.6.2.4. Reimbursement scenario
    • 9.6.2.5. Argentina market estimates and forecasts, 2021 - 2033
• 9.7. MEA
  • 9.7.1. South Africa
    • 9.7.1.1. Key country dynamics
    • 9.7.1.2. Competitive scenario
    • 9.7.1.3. Regulatory framework
    • 9.7.1.4. Reimbursement scenario
    • 9.7.1.5. South Africa market estimates and forecasts, 2021 - 2033
  • 9.7.2. Saudi Arabia
    • 9.7.2.1. Key country dynamics
    • 9.7.2.2. Competitive scenario
    • 9.7.2.3. Regulatory framework
    • 9.7.2.4. Reimbursement scenario
    • 9.7.2.5. Saudi Arabia market estimates and forecasts, 2021 - 2033
  • 9.7.3. UAE
    • 9.7.3.1. Key country dynamics
    • 9.7.3.2. Competitive scenario
    • 9.7.3.3. Regulatory framework
    • 9.7.3.4. Reimbursement scenario
    • 9.7.3.5. UAE market estimates and forecasts, 2021 - 2033
  • 9.7.4. Kuwait
    • 9.7.4.1. Key country dynamics
    • 9.7.4.2. Competitive scenario
    • 9.7.4.3. Regulatory framework
    • 9.7.4.4. Reimbursement scenario
    • 9.7.4.5. Kuwait market estimates and forecasts, 2021 - 2033

Chapter 10. Competitive Landscape

• 10.1. Recent Developments & Impact Analysis, By Key Market Participants
• 10.2. Company/Competition Categorization
  • 10.2.1. Innovators
• 10.3. Vendor Landscape
  • 10.3.1. List of key distributors and channel partners
  • 10.3.2. Key customers
  • 10.3.3. Global Key company market share analysis, 2024
  • 10.3.4. B. Braun SE
    • 10.3.4.1. Company overview
    • 10.3.4.2. Financial performance
    • 10.3.4.3. Product Type benchmarking
    • 10.3.4.4. Strategic initiatives
  • 10.3.5. Nalu Medical, Inc.
    • 10.3.5.1. Company overview
    • 10.3.5.2. Financial performance
    • 10.3.5.3. Product Type benchmarking
    • 10.3.5.4. Strategic initiatives
  • 10.3.6. Curonix LLC.
    • 10.3.6.1. Company overview
    • 10.3.6.2. Financial performance
    • 10.3.6.3. Product Type benchmarking
    • 10.3.6.4. Strategic initiatives
  • 10.3.7. SPR
    • 10.3.7.1. Company overview
    • 10.3.7.2. Financial performance
    • 10.3.7.3. Product Type benchmarking
    • 10.3.7.4. Strategic initiatives
  • 10.3.8. Vygon
    • 10.3.8.1. Company overview
    • 10.3.8.2. Financial performance
    • 10.3.8.3. Product Type benchmarking
    • 10.3.8.4. Strategic initiatives
  • 10.3.9. AirLife
    • 10.3.9.1. Company overview
    • 10.3.9.2. Financial performance
    • 10.3.9.3. Product Type benchmarking
    • 10.3.9.4. Strategic initiatives
  • 10.3.10. Neuspera Medical
    • 10.3.10.1. Company overview
    • 10.3.10.2. Financial performance
    • 10.3.10.3. Product Type benchmarking
    • 10.3.10.4. Strategic initiatives
  • 10.3.11. AVNS
    • 10.3.11.1. Company overview
    • 10.3.11.2. Financial performance
    • 10.3.11.3. Product Type benchmarking
    • 10.3.11.4. Strategic initiatives
  • 10.3.12. Mercury Medical
    • 10.3.12.1. Company overview
    • 10.3.12.2. Financial performance
    • 10.3.12.3. Product Type benchmarking
    • 10.3.12.4. Strategic initiatives
  • 10.3.13. Medilogix
    • 10.3.13.1. Company overview
    • 10.3.13.2. Financial performance
    • 10.3.13.3. Product Type benchmarking
    • 10.3.13.4. Strategic initiatives
  • 10.3.14. Anesthesia Associates, Inc.
    • 10.3.14.1. Company overview
    • 10.3.14.2. Financial performance
    • 10.3.14.3. Product Type benchmarking
    • 10.3.14.4. Strategic initiatives
  • 10.3.15. Medtronic
    • 10.3.15.1. Company overview
    • 10.3.15.2. Financial performance
    • 10.3.15.3. Product Type benchmarking
    • 10.3.15.4. Strategic initiatives
  • 10.3.16. Boston Scientific Corporation
    • 10.3.16.1. Company overview
    • 10.3.16.2. Financial performance
    • 10.3.16.3. Product Type benchmarking
    • 10.3.16.4. Strategic initiatives
  • 10.3.17. Abbott
    • 10.3.17.1. Company overview
    • 10.3.17.2. Financial performance
    • 10.3.17.3. Product Type benchmarking
    • 10.3.17.4. Strategic initiatives
  • 10.3.18. Bioventus
    • 10.3.18.1. Company overview
    • 10.3.18.2. Financial performance
    • 10.3.18.3. Product Type benchmarking
    • 10.3.18.4. Strategic initiatives
  • 10.3.19. Checkpoint Surgical Inc.
    • 10.3.19.1. Company overview
    • 10.3.19.2. Financial performance
    • 10.3.19.3. Product Type benchmarking
    • 10.3.19.4. Strategic initiatives
  • 10.3.20. NEURIMPULSE s.r.l.
    • 10.3.20.1. Company overview
    • 10.3.20.2. Financial performance
    • 10.3.20.3. Product Type benchmarking
    • 10.3.20.4. Strategic initiatives
  • 10.3.21. Nervonik, Inc
    • 10.3.21.1. Company overview
    • 10.3.21.2. Financial performance
    • 10.3.21.3. Product Type benchmarking
    • 10.3.21.4. Strategic initiatives
  • 10.3.22. Epineuron Technologies Inc.
    • 10.3.22.1. Company overview
    • 10.3.22.2. Financial performance
    • 10.3.22.3. Product Type benchmarking
    • 10.3.22.4. Strategic initiatives
• 10.4. Heat Map Analysis/ Company Market Position Analysis
• 10.5. Estimated Company Market Share Analysis, 2024
• 10.6. List of Other Key Market Players